Blaine Davis
Chief Financial Officer
Replay available
Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call
Selecta Biosciences, Inc. (NASDAQ: SELB) Q1 2023 earnings conference call, held 2023-05-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Karsten Brunn
President & Chief Executive Officer
Peter Traber
Chief Medical Officer
Joseph Schwartz
Analyst, SVB Leerink
Kristen Kolaska
Analyst, Kantor Fitzgerald
John Newman
Analyst, Canaccord
Gil Bloom
Analyst, Needham & Co.
Yui Ear
Analyst, Mizuho
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cartesian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:06.194 Good morning and thank you for joining the Selective Biosciences first quarter 2023 earnings 00:00:06.194 -- 00:00:11.318 call. At this time, all participants are in a listen-only mode. 00:00:11.318 -- 00:00:16.102 Following management's remarks, we will hold a question and answer session. 00:00:16.102 -- 00:00:21.486 At that time, lines will be open for you. If anyone should require operator assistance, 00:00:21.486 -- 00:00:25.529 please press star then zero on your touch-tone phone. 00:00:25.529 -- 00:00:30.591 I would now like to turn the call over to Blaine Davis, Chief Financial Officer at Selecta. 00:00:30.591 -- 00:00:33.391 Please go ahead. 00:00:33.432 -- 00:00:38.473 Thank you, and good morning, everyone. Welcome to our first quarter 2023 00:00:38.473 -- 00:00:42.115 financial results and business update conference call. 00:00:42.115 -- 00:00:46.476 The press release reporting our financial results is available in the investor and media 00:00:46.476 -- 00:00:51.117 section of Selecta's website at www.selectabio.com. 00:00:52.318 -- 00:00:58.481 and in our quarterly report on Form 10-Q for the quarter ended March 31st, 2023, 00:00:58.481 -- 00:01:02.183 which was filed earlier this morning with the Securities and Exchange Commission of the 00:01:02.183 -- 00:01:04.024 SEC. 00:01:04.024 -- 00:01:08.386 Joining me on today's call are Karsten Brunn, President and Chief Executive Officer, 00:01:08.386 -- 00:01:15.308 Kay Kishimoto, Chief Scientific Officer, and Peter Traber, our Chief Medical Officer. 00:01:15.530 -- 00:01:19.675 During today's call, we will be making certain forward-looking statements, including, 00:01:19.675 -- 00:01:24.758 without limitation, statements about the potential safety, efficacy, and regulatory ...